1 – Program overview

This external quality assessment program allows you to check the accuracy of the results rendered by your point of care testing according to the standard ISO 15189. As the samples are ready for use, they can be analysed directly by healthcare staff as a real patient sample.

3 possible cumulative options (each option is sold separately):

• Biochemistry / Haematology option (BDB).
• INR option (BDH).
• D-dimer option (BDDI).

For the 3 options, one registration allows access to 6 entries of results per analyte.

Program limited to metropolitan France, Corsica excluded.

2 – Assessment frequency

Biochemistry / Haematology (BDB) option:

• Number of surveys per year: 4
• Number of control samples per survey: 1
• Number of samples per year: 4

INR Option (BDH):

• Number of surveys per year: 4
• Number of control samples per survey: 1 or 2
• Number of samples per year: 6

D-dimer option (BDDI):

• Number of surveys per year: 4
• Number of control samples per survey: 1 or 2
• Number of samples per year: 6

3 – List of analytes assessed 

Biochemistry / Haematology option (BDB):

• Creatinine
• CRP (quantitative methods)
• CRP (semi-quantitative methods)
• Glucose*
• HbA1c
• hCG (quantitative methods)
• hCG (qualitative methods)
• Haematocrit
• Haemoglobin
• Lactate*
• Urea

INR option (BDH):

• INR

D-dimer option (BDDI):

• D-dimer

4 – Description of the control samples

Biochemistry / Haematology (BDB) option:

Fresh human control blood (1.2 mL samples, ready to use). Sampling carried out on the day of dispatch, delivered within 24 hours and to be assayed preferably on the day of receipt.

INR Option (BDH):

Liquid human control plasma (0.3 mL samples, ready to use)

D-dimer option (BDDI):

Liquid human control plasma (0.5 mL samples, ready to use)